| # | Drug | Count |
|---|---|---|
| 0 | POLYETHYLENE GLYCOL 3350 | 96 |
| 1 | INSULIN LISPRO | 34 |
| 2 | FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE | 30 |
| 3 | UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE | 17 |
| 4 | METFORMIN | 14 |
| 5 | METFORMIN ER 500 MG | 14 |
| 6 | METFORMIN ER 750 MG | 14 |
| 7 | ADALIMUMAB | 13 |
| 8 | FLUTICASONE PROPIONATE AND SALMETEROL | 11 |
| 9 | NAPROXEN SODIUM | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PIMOZIDE | 1 | 0.0021 |
| 1 | TAURINE | 1 | 0.0013 |
| 2 | INFLIXIMAB-DYYB | 4 | 0.0012 |
| 3 | NAFCILLIN SODIUM | 1 | 0.0011 |
| 4 | POLYETHYLENE GLYCOL 3350 | 96 | 0.0010 |
| 5 | FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE | 30 | 0.0008 |
| 6 | PYRIMETHAMINE | 1 | 0.0008 |
| 7 | PSYLLIUM HUSK | 1 | 0.0007 |
| 8 | FLUCYTOSINE | 1 | 0.0007 |
| 9 | RALTEGRAVIR | 3 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Osmotic Laxative [EPC] | 97 |
| 1 | Insulin Analog [EPC] | 43 |
| 2 | Corticosteroid [EPC] | 12 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 12 |
| 4 | Atypical Antipsychotic [EPC] | 10 |
| 5 | Proton Pump Inhibitor [EPC] | 10 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 9 |
| 7 | Factor Xa Inhibitor [EPC] | 8 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 8 |
| 9 | GLP-1 Receptor Agonist [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 1 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 1 | 0.0008 |
| 2 | Nucleoside Analog Antifungal [EPC] | 1 | 0.0007 |
| 3 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 4 | Estrogen Agonist/Antagonist [EPC] | 1 | 0.0004 |
| 5 | Osmotic Laxative [EPC] | 97 | 0.0003 |
| 6 | Chloride Channel Activator [EPC] | 2 | 0.0002 |
| 7 | Provitamin D2 Compound [EPC] | 6 | 0.0002 |
| 8 | Insulin [EPC] | 7 | 0.0002 |
| 9 | RNA Synthetase Inhibitor Antibacterial [EPC] | 2 | 0.0001 |